Appendix E - National Coverage Determinations Manual / HUMAN_IMMUNODEFICIENCY_VIRUS

Why This Topic Matters

Coverage policy for HIV viral load testing affects medical necessity review, billing compliance, and laboratory ordering practices. Understanding the scope of the guidance helps distinguish prognostic monitoring from diagnostic use and supports proper alignment with Medicare policy.

Article Sections

1. Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring)

   Introduces the topic of HIV RNA quantification and its role in prognosis and monitoring. Summarizes the general laboratory approach and the related use of immune status assessment.

2. Indications

   Lists the general clinical situations in which HIV RNA measurement may be considered. Includes baseline and periodic assessment contexts tied to confirmed or suspected infection.

3. Limitations

   Describes broad restrictions and cautions on the use of HIV RNA measurement. Covers timing, repeat measurement considerations, assay consistency, and awareness of current regulatory status.